Informative censoring of surrogate end-point data in phase 3 oncology trials

Shai Gilboa, Yarden Pras, Aviv Mataraso, David Bomze, Gal Markel*, Tomer Meirson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Informative censoring of surrogate end-point data in phase 3 oncology trials'. Together they form a unique fingerprint.

Keyphrases

Mathematics

Nursing and Health Professions

Immunology and Microbiology

Agricultural and Biological Sciences